Media Summary: With education and policies that keep physicians and patients in charge of If you were recently diagnosed with a chronic disease, or use infusions or injectables to manage your health, you might be familiar ... Don't miss our upcoming webinars: Subscribe today! In this webinar: ○ Discussion on

Biologics And Biosimilars Increasing Treatment Options - Detailed Analysis & Overview

With education and policies that keep physicians and patients in charge of If you were recently diagnosed with a chronic disease, or use infusions or injectables to manage your health, you might be familiar ... Don't miss our upcoming webinars: Subscribe today! In this webinar: ○ Discussion on The ACMA takes a detailed look into the world of Professor Angela Thomas, Royal Hospital for Sick Children, Edinburgh, UK, presented at Pharmacology 2016, the British ... Learn about Health Canada's definition of extrapolation, their guidance for clinical trials and their rationale for selected

Have you considered or been approached about switching from a At times, it can take patients and their physicians years to find the right

Photo Gallery

Biologics and Biosimilars: Increasing Treatment Options
Biosimilar Medications — What Patients Need to Know
Biologics, Unbranded Biologics, and Biosimilars - What is the difference?
Biologics & Biosimilars: Insights for Patients & Physicians
What are biologics & biosimilars?
Understanding Biologic and Biosimilar Medicines
Biologics and Biosimilars: Information for Healthcare Providers
WEBINAR: Biologics & Biosimilars
Future of Biosimilar Medications
Biosimilars: Treatment Options for Patients
Biologics and Biosimilars Interchangeability: A Deep Dive with Industry Experts
Professor Angela Thomas: "Regulation of biologics & biosimilars"
Sponsored
Sponsored
View Detailed Profile
Biologics and Biosimilars: Increasing Treatment Options

Biologics and Biosimilars: Increasing Treatment Options

With education and policies that keep physicians and patients in charge of

Biosimilar Medications — What Patients Need to Know

Biosimilar Medications — What Patients Need to Know

What are

Sponsored
Biologics, Unbranded Biologics, and Biosimilars - What is the difference?

Biologics, Unbranded Biologics, and Biosimilars - What is the difference?

If you were recently diagnosed with a chronic disease, or use infusions or injectables to manage your health, you might be familiar ...

Biologics & Biosimilars: Insights for Patients & Physicians

Biologics & Biosimilars: Insights for Patients & Physicians

National Webinar hosted by AARDA & the

What are biologics & biosimilars?

What are biologics & biosimilars?

Learn more about

Sponsored
Understanding Biologic and Biosimilar Medicines

Understanding Biologic and Biosimilar Medicines

Biologic

Biologics and Biosimilars: Information for Healthcare Providers

Biologics and Biosimilars: Information for Healthcare Providers

Learn about

WEBINAR: Biologics & Biosimilars

WEBINAR: Biologics & Biosimilars

Don't miss our upcoming webinars: Subscribe today! In this webinar: ○ Discussion on

Future of Biosimilar Medications

Future of Biosimilar Medications

Future of

Biosimilars: Treatment Options for Patients

Biosimilars: Treatment Options for Patients

Learn about

Biologics and Biosimilars Interchangeability: A Deep Dive with Industry Experts

Biologics and Biosimilars Interchangeability: A Deep Dive with Industry Experts

The ACMA takes a detailed look into the world of

Professor Angela Thomas: "Regulation of biologics & biosimilars"

Professor Angela Thomas: "Regulation of biologics & biosimilars"

Professor Angela Thomas, Royal Hospital for Sick Children, Edinburgh, UK, presented at Pharmacology 2016, the British ...

Biologics, Biosimilars and Generics for the Treatment of Retinal Disease

Biologics, Biosimilars and Generics for the Treatment of Retinal Disease

By Dr. Pamela Weber.

Innovator Biologics vs. Biosimilars vs. Interchangeables

Innovator Biologics vs. Biosimilars vs. Interchangeables

Biologics

Biologics and Biosimilars: Extrapolation of Indications – Information for Healthcare Providers

Biologics and Biosimilars: Extrapolation of Indications – Information for Healthcare Providers

Learn about Health Canada's definition of extrapolation, their guidance for clinical trials and their rationale for selected

Better Understanding Biosimilar Medications

Better Understanding Biosimilar Medications

Have you considered or been approached about switching from a

Biologics: An Important Treatment Choice

Biologics: An Important Treatment Choice

At times, it can take patients and their physicians years to find the right

Biologic Drugs and Biosimilars

Biologic Drugs and Biosimilars

What are

The Promise of Biosimilars

The Promise of Biosimilars

What are the promises that

Comparison of Biologics to Biosimilars Versus Generics

Comparison of Biologics to Biosimilars Versus Generics

Compare